M. Aulí

Therapeutic Effect of a Novel Phosphatidylinositol-3-Kinase δ Inhibitor in Experimental Epidermolysis Bullosa Acquisita

H. Koga, D. Zillikens, C. Balagué, 2018, Front. Immunol..

Adaptation to acetaminophen exposure elicits major changes in expression and distribution of the hepatic proteome

N. Kitteringham, B. K. Park, R. Eakins, 2015, Scientific Reports.

Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.

N. Prats, M. Lehner, V. Segarra, 2015, Pulmonary pharmacology & therapeutics.

The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.

G. Milligan, G. Tarrasón, S. Kunkel, 2011, International immunopharmacology.

Neuromuscular changes in a rat model of colitis

Y. Nasser, Juan F Burgueño, W. Ho, 2008, Autonomic Neuroscience.